 |
|
 |
|
 |
|
|
HIV vaccines currently in development (CAT No: VAVS017, published September 2009).
With the recent news that the combination HIV vaccine candidate ALVAC-HIV/VaxGen gp120 B/E may have shown some protection against infection in Thailand, the spotlight will return to HIV vaccine research.
As part of a new series of analysis investigating the topic we list below current ongoing HIV vaccine programs within clinical development.
This output is available from the VacZine Analytics Vaccine Pipeline/IP review (published September 2009).
For information on how to order:
e-mail: Info@vacZine-analytics.com
| Documents on this page are available in Portable Document Format (PDF) 
|
|
|
|
|
|
